https://www.selleckchem.com/pr....oducts/chir-99021-ct
Little is known about medical cannabis (MC)-related care for patients with cancer using MC. Semistructured telephone interviews were conducted in a convenience sample of individuals (n = 24) with physician-confirmed oncologic diagnoses and state/district authorization to use MC (Arizona, California, Florida, Illinois, Massachusetts, Oregon, New York, and Washington, DC) from April 2017 to March 2019. Standard qualitative techniques were used to assess the degree of MC-related health care oversight, MC practices, and key i
Mi piace
Commento
Condividi
